Link Cell Therapies secures $60 million in Series A funding led by Johnson & Johnson to advance its CAR-T therapies for solid and liquid tumors.
Amount Raised
$60 Million
Round Type
Series A
South San FranciscoBiotechnologyHealth CareTherapeuticsInvestors
Description
Link Cell Therapies has launched with a $60 million Series A financing round backed by Johnson & Johnson and other investors. Their innovative platform enables the creation of next-generation CAR-T therapeutics targeting multiple antigens. This approach aims to improve cancer-targeted therapies while minimizing harm to healthy tissues. The company has raised a total of $92 million across seed and Series A financings.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Link Cell Therapies that raised within 45 days of this round, from Fundz verified event records.
- Tenpoint Therapeutics raised $235M (Series B) on January 29, 2026.
- PranaX raised $17M (Series A) on January 29, 2026.
- Altido Bio raised $13M (Seed) on January 28, 2026.
- Stellular Bio raised an undisclosed amount (Funding Round) on January 28, 2026.
- CraniUS raised $20M (Series B) on January 28, 2026.
- TRex Bio raised $50M (Funding Round) on January 27, 2026.
Who to call at Link Cell Therapies, and when
A new round usually means Link Cell Therapies is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Link Cell Therapies raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Link Cell Therapies, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Link Cell Therapies. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Link Cell Therapies raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansLink Cell Therapies raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.